Feacalibacterium prausnitzii Attenuates CKD via Butyrate-Renal GPR43 Axis

Article (Faculty180)

cited authors

  • Li, Hong-Ba B; Xu, Meng-L L; Xu, Xu-Don D; Tang, Yu-Ya Y; Jiang, Hong-L L; Li, Lu; Xia, Wen-Ji J; Cui, Nan; Bai, Juan; Dai, Zhi-Min M; Han, Bei; Li, Ying; Peng, Bo; Dong, Yuan-Yua Y; Aryal, Sachin; Manandhar, Ishan; Eladawi, Mahmoud Al A; Shukla, Rammohan; Kang, Yu-Min M; Joe, Bina; Yang, Tao

description

  • <p><em>This study provides mechanistic insight and identifies F. prausnitzii as a promising microbiome-based therapeutic strategy for chronic kidney diseases. This paper was featured by Circulation Research, and has been cited 144 times from its online Oct 2022 to Aug 2025.</em></p>

authors

publication date

  • 2022

published in

start page

  • e120

end page

  • e134

volume

  • 131